Lysophospholipids act as mediators via the activation of cell surface GPCRs, and as intracellular second messengers through PPARγ activation and inhibition in diseases such as atherosclerosis, dementia, and spinal cord injury. The gene discussed is PPARG; the disease is atherosclerosis.